Remedent, Inc. (REMI)
USD 0.05
(25.0%)
USD 0.05
(25.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -122.89 Thousand USD | 56.58% |
| 2023 | -283.03 Thousand USD | -189.15% |
| 2022 | 317.48 Thousand USD | 1085.35% |
| 2021 | -32.22 Thousand USD | 93.28% |
| 2020 | -479.6 Thousand USD | 33.14% |
| 2019 | -717.35 Thousand USD | -138.51% |
| 2018 | -300.76 Thousand USD | 71.89% |
| 2017 | -1.06 Million USD | -14920.95% |
| 2016 | 7218.00 USD | -93.15% |
| 2015 | 105.41 Thousand USD | 114.3% |
| 2014 | -737.27 Thousand USD | 59.35% |
| 2013 | -1.81 Million USD | -261.06% |
| 2012 | -502.35 Thousand USD | -317.27% |
| 2011 | 231.21 Thousand USD | 107.84% |
| 2010 | -2.94 Million USD | -211.84% |
| 2009 | -945.67 Thousand USD | 69.21% |
| 2008 | -3.07 Million USD | -120.15% |
| 2007 | -1.39 Million USD | 64.06% |
| 2006 | -3.88 Million USD | -537.19% |
| 2005 | 887.76 Thousand USD | 23.54% |
| 2004 | 718.58 Thousand USD | 175.07% |
| 2003 | -957.21 Thousand USD | 49.47% |
| 2002 | -1.89 Million USD | -231.7% |
| 2001 | -571.05 Thousand USD | 35.0% |
| 2000 | -878.5 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -124.13 Thousand USD | -460.83% |
| 2024 FY | -122.89 Thousand USD | 56.58% |
| 2024 Q1 | -25.04 Thousand USD | 69.33% |
| 2024 Q2 | -8130.00 USD | 67.53% |
| 2024 Q3 | 34.4 Thousand USD | 523.12% |
| 2023 Q4 | -81.65 Thousand USD | -25.77% |
| 2023 FY | -283.03 Thousand USD | -189.15% |
| 2023 Q3 | -64.92 Thousand USD | 55.07% |
| 2023 Q2 | -144.48 Thousand USD | -1901.5% |
| 2023 Q1 | 8020.00 USD | 0.0% |
| 2022 FY | 317.48 Thousand USD | 1085.35% |
| 2021 FY | -32.22 Thousand USD | 93.28% |
| 2021 Q2 | 3110.00 USD | -61.98% |
| 2021 Q3 | 102.17 Thousand USD | 3185.27% |
| 2021 Q1 | 8179.00 USD | 104.24% |
| 2020 Q4 | -192.89 Thousand USD | -56.8% |
| 2020 Q3 | -123.01 Thousand USD | 26.73% |
| 2020 Q2 | -167.9 Thousand USD | -149.96% |
| 2020 Q1 | -67.17 Thousand USD | 70.24% |
| 2020 FY | -479.6 Thousand USD | 33.14% |
| 2019 Q2 | -112.64 Thousand USD | 28.06% |
| 2019 Q4 | -225.74 Thousand USD | -1.51% |
| 2019 Q3 | -222.37 Thousand USD | -97.42% |
| 2019 FY | -717.35 Thousand USD | -138.51% |
| 2019 Q1 | -156.58 Thousand USD | 34.34% |
| 2018 Q2 | -46.24 Thousand USD | -739.72% |
| 2018 Q3 | -23.27 Thousand USD | 49.66% |
| 2018 Q4 | -238.47 Thousand USD | -924.44% |
| 2018 Q1 | 7229.00 USD | 100.74% |
| 2018 FY | -300.76 Thousand USD | 71.89% |
| 2017 FY | -1.06 Million USD | -14920.95% |
| 2017 Q2 | -60.79 Thousand USD | -1979.26% |
| 2017 Q3 | -31.16 Thousand USD | 48.74% |
| 2017 Q4 | -981.05 Thousand USD | -3047.93% |
| 2017 Q1 | 3235.00 USD | 101.45% |
| 2016 FY | 7218.00 USD | -93.15% |
| 2016 Q1 | 206.68 Thousand USD | 403.01% |
| 2016 Q4 | -223.29 Thousand USD | -824.5% |
| 2016 Q2 | 47.98 Thousand USD | -76.78% |
| 2016 Q3 | -24.15 Thousand USD | -150.34% |
| 2015 Q2 | 10.93 Thousand USD | 307.43% |
| 2015 Q4 | 41.08 Thousand USD | -29.96% |
| 2015 Q3 | 58.66 Thousand USD | 436.3% |
| 2015 Q1 | -5273.00 USD | 99.16% |
| 2015 FY | 105.41 Thousand USD | 114.3% |
| 2014 Q2 | -27.02 Thousand USD | 66.48% |
| 2014 Q3 | -4021.00 USD | 85.12% |
| 2014 FY | -737.27 Thousand USD | 59.35% |
| 2014 Q1 | -80.61 Thousand USD | -191.53% |
| 2014 Q4 | -625.61 Thousand USD | -15458.79% |
| 2013 Q3 | -515.28 Thousand USD | 19.36% |
| 2013 FY | -1.81 Million USD | -261.06% |
| 2013 Q4 | 88.07 Thousand USD | 117.09% |
| 2013 Q2 | -638.97 Thousand USD | 14.54% |
| 2013 Q1 | -747.66 Thousand USD | -101.66% |
| 2012 Q2 | 17.75 Thousand USD | -75.08% |
| 2012 Q3 | -220.57 Thousand USD | -1342.68% |
| 2012 Q4 | -370.75 Thousand USD | -68.09% |
| 2012 FY | -502.35 Thousand USD | -317.27% |
| 2012 Q1 | 71.22 Thousand USD | 107.63% |
| 2011 Q3 | 211.49 Thousand USD | -41.73% |
| 2011 FY | 231.21 Thousand USD | 107.84% |
| 2011 Q1 | 589.98 Thousand USD | 227.61% |
| 2011 Q2 | 362.98 Thousand USD | -38.48% |
| 2011 Q4 | -933.24 Thousand USD | -541.27% |
| 2010 Q2 | -994.08 Thousand USD | -87.94% |
| 2010 Q4 | -462.33 Thousand USD | 52.02% |
| 2010 FY | -2.94 Million USD | -211.84% |
| 2010 Q1 | -528.94 Thousand USD | -13.06% |
| 2010 Q3 | -963.65 Thousand USD | 3.06% |
| 2009 Q3 | -467.23 Thousand USD | -30.21% |
| 2009 FY | -945.67 Thousand USD | 69.21% |
| 2009 Q4 | -467.83 Thousand USD | -0.13% |
| 2009 Q1 | 348.22 Thousand USD | 163.33% |
| 2009 Q2 | -358.83 Thousand USD | -203.05% |
| 2008 Q3 | -1.08 Million USD | -1.93% |
| 2008 Q1 | -363.51 Thousand USD | -462.13% |
| 2008 FY | -3.07 Million USD | -120.15% |
| 2008 Q4 | -549.81 Thousand USD | 49.52% |
| 2008 Q2 | -1.06 Million USD | -193.95% |
| 2007 Q4 | 100.38 Thousand USD | 115.99% |
| 2007 FY | -1.39 Million USD | 64.06% |
| 2007 Q3 | -627.73 Thousand USD | -2212.17% |
| 2007 Q2 | -27.14 Thousand USD | 96.77% |
| 2007 Q1 | -840.49 Thousand USD | 2.96% |
| 2006 Q4 | -866.11 Thousand USD | 49.11% |
| 2006 FY | -3.88 Million USD | -537.19% |
| 2006 Q1 | -972.46 Thousand USD | -877.81% |
| 2006 Q2 | -340.65 Thousand USD | 64.97% |
| 2006 Q3 | -1.7 Million USD | -399.63% |
| 2005 Q3 | 242.51 Thousand USD | 16.57% |
| 2005 FY | 887.76 Thousand USD | 23.54% |
| 2005 Q2 | 208.04 Thousand USD | -33.36% |
| 2005 Q1 | 312.17 Thousand USD | -11.82% |
| 2005 Q4 | 125.02 Thousand USD | -48.45% |
| 2004 Q4 | 354.02 Thousand USD | -8.55% |
| 2004 Q1 | 17.75 Thousand USD | 103.9% |
| 2004 Q2 | -40.31 Thousand USD | -327.09% |
| 2004 FY | 718.58 Thousand USD | 175.07% |
| 2004 Q3 | 387.12 Thousand USD | 1060.35% |
| 2003 Q1 | -143.37 Thousand USD | 79.55% |
| 2003 FY | -957.21 Thousand USD | 49.47% |
| 2003 Q4 | -455.71 Thousand USD | -308.13% |
| 2003 Q3 | -111.66 Thousand USD | 54.69% |
| 2003 Q2 | -246.45 Thousand USD | -71.89% |
| 2002 Q4 | -700.95 Thousand USD | -64.91% |
| 2002 FY | -1.89 Million USD | -231.7% |
| 2002 Q1 | -354.45 Thousand USD | -92.99% |
| 2002 Q2 | -413.74 Thousand USD | -16.73% |
| 2002 Q3 | -425.05 Thousand USD | -2.74% |
| 2001 FY | -571.05 Thousand USD | 35.0% |
| 2001 Q2 | -87.69 Thousand USD | 45.71% |
| 2001 Q3 | -141.26 Thousand USD | -61.08% |
| 2001 Q4 | -183.66 Thousand USD | -30.02% |
| 2001 Q1 | -161.52 Thousand USD | 0.0% |
| 2000 FY | -878.5 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 110.556% |
| Ansell Limited | 129.3 Million USD | 100.095% |
| Ansell Limited | 129.3 Million USD | 100.095% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 100.395% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 92.299% |
| Psykey, Inc. | -797.5 Thousand USD | 84.591% |
| ConvaTec Group Plc | 262.7 Million USD | 100.047% |
| ConvaTec Group Plc | 262.7 Million USD | 100.047% |
| Encision Inc. | -640.78 Thousand USD | 80.822% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 13.342% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -11.789% |
| Innovative MedTech Inc. | -4.27 Million USD | 97.125% |
| LifePoint, Inc. | -7.49 Million USD | 98.36% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 98.104% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 137.239% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 73.701% |
| SmileDirectClub, Inc. | -241.15 Million USD | 99.949% |
| Sector 10, Inc. | -39.84 Thousand USD | -208.428% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.038% |
| SheerVision, Inc. | 155.72 Thousand USD | 178.914% |
| United Health Products, Inc. | -2.42 Million USD | 94.936% |
| Vasamed, Inc. | 4.74 Million USD | 102.591% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 94.643% |
| Yubo International Biotech Limited | -1.2 Million USD | 89.804% |